Estimates of US influenza-associated deaths made using four different methods
William W Thompson, Eric Weintraub, Praveen Dhankhar, Po-Yung Cheng, Lynnette Brammer, Martin I Meltzer, Joseph S Bresee, David K Shay, William W Thompson, Eric Weintraub, Praveen Dhankhar, Po-Yung Cheng, Lynnette Brammer, Martin I Meltzer, Joseph S Bresee, David K Shay
Abstract
Background: A wide range of methods have been used for estimating influenza-associated deaths in temperate countries. Direct comparisons of estimates produced by using different models with US mortality data have not been published.
Objective: Compare estimates of US influenza-associated deaths made by using four models and summarize strengths and weaknesses of each model.
Methods: US mortality data from the 1972-1973 through 2002-2003 respiratory seasons and World Health Organization influenza surveillance data were used to estimate influenza-associated respiratory and circulatory deaths. Four models were used: (i) rate-difference (using peri-season or summer-season baselines), (ii) Serfling least squares cyclical regression, (iii) Serfling-Poisson regression, (iv) and autoregressive integrated moving average models.
Results: Annual estimates of influenza-associated deaths made using each model were similar and positively correlated, except for estimates from the summer-season rate-difference model, which were consistently higher. From the 1976/1977 through the 2002/2003 seasons the, the Poisson regression models estimated that an annual average of 25,470 [95% confidence interval (CI) 19,781-31,159] influenza-associated respiratory and circulatory deaths [9.9 deaths per 100,000 (95% CI 7.9-11.9)], while peri-season rate-difference models using a 15% threshold estimated an annual average of 22,454 (95% CI 16,189-28,719) deaths [8.6 deaths per 100,000 (95% CI 6.4-10.9)].
Conclusions: Estimates of influenza-associated mortality were of similar magnitude. Poisson regression models permit the estimation of deaths associated with influenza A and B, but require robust viral surveillance data. By contrast, simple peri-season rate-difference models may prove useful for estimating mortality in countries with sparse viral surveillance data or complex influenza seasonality.
References
- Serfling RE. Methods for current statistical analysis of excess pneumonia‐influenza deaths. Public Health Rep 1963; 78:494–505.
- Lui KJ, Kendal AP. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health 1987; 77:712–716.
- Simonsen L, Fukuda K, Schonberger LB, Cox NJ. The impact of influenza epidemics on hospitalizations. J Infect Dis 2000; 181:831–837.
- Thompson WW, Shay DK, Weintraub E et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179–186.
- Meltzer MI, Cox NJ, Fukuda K. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect Dis 1999; 5:659–671.
- Nichol KL. The efficacy, effectiveness and cost‐effectiveness of inactivated influenza virus vaccines. Vaccine 2003; 21:1769–1775.
- Bridges CB, Harper SA, Fukuda K, Uyeki TM, Cox NJ, Singleton JA. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2003; 52(RR‐8):1–34.
- Thompson WW, Shay DK, Weintraub E et al. Influenza‐associated hospitalizations in the United States. JAMA 2004; 292:1333–1340.
- Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998; 178:53–60.
- Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 1999; 130:397–403.
- Nichol KL, Wuorenma J, Von Sternberg T. Benefits of influenza vaccination for low‐, intermediate‐, and high‐risk senior citizens. Arch Intern Med 1998; 158:1769–1776.
- Noble GR. Epidemiogical and clinical aspects of influenza; in Bears AS. (ed): Basic and Applied Influenza Research. Boca Raton, FL: CRC Press, 1982, 11–50.
- Choi K, Thacker SB. Mortality during influenza epidemics in the United States, 1967–1978. Am J Public Health 1982; 72:1280–1283.
- Barker WH, Mullooly JP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol 1980; 112:798–811.
- Barker WH, Mullooly JP. Pneumonia and influenza deaths during epidemics: implications for prevention. Arch Intern Med 1982; 142:85–89.
- Izurieta HS, Thompson WW, Kramarz P et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000; 342:232–239.
- O’Brien MA, Uyeki TM, Shay DK, et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics 2004; 113(3 Pt 1):585–593.
- Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1997; 87:1944–1950.
- Neuzil KM, Maynard C, Griffin MR, Heagerty P. Winter respiratory viruses and health care use: a population‐based study in the northwest United States. Clin Infect Dis 2003; 37:201–207.
- Choi K, Thacker SB. An evaluation of influenza mortality surveillance, 1962–1979 I. Time series forecasts of expected pneumonia and influenza deaths. Am J Epidemiol 1981; 113:215–226.
- Stroup DF, Thacker SB, Herndon JL. Application of multiple time series analysis to the estimation of pneumonia and influenza mortality by age 1962–1983. Stat Med 1988; 7:1045–1059.
- Brammer TL, Izurieta HS, Fukuda K et al. Surveillance for influenza–United States, 1994–95, 1995–96, and 1996–97 seasons. Morb Mortal Wkly Rep CDC Surveill Summ 2000; 49:13–28.
- Vital Statistics Mortality Data, Multiple Cause Detail, 1972–2004 . Public Use Data Tapes Contents and Documentation Package. Hyattsville, MD: National Center for Health Statistics, 2004.
- World Health Organization . Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, based on recommendations of the Ninth Revision Conference, 1975. Geneva: World Health Organization, 1977.
- Mullooly JP, Bridges CB, Thompson WW et al. Influenza‐ and RSV‐associated hospitalizations among adults. Vaccine 2007; 25:846–855.
- Simonsen L, Clarke MJ, Stroup DF, Williamson GD, Arden NH, Cox NJ. A method for timely assessment of influenza‐associated mortality in the United States. Epidemiology 1997; 8:390–395.
- Thompson WW, Weintraub E, Shay DK, Brammer L, Cox NJ, Fukuda K. Influenza‐attributable hospitalizations in the United States; in Osterhaus A, Cox NJ. (eds): Options for the Control of Influenza V. Hampson: Elsevier Science, 2003.
- Thompson WW, Shay DK, Weintraub E, Brammer L, Cox NJ, Fukuda K. Influenza‐attributable deaths among the elderly in the United States; in Osterhaus A, Cox NJ. (eds): Options for the Control of Influenza V. Hampson: Elsevier Science, 2003.
- US Bureau of the Census . Intercensal Estimates of the Population by Age, Sex, and Race: 1970‐2000. Washington DC: US Bureau of the Census, 2005.
- Thompson WW, Shay DK, Weintraub E et al. In Reply to Letters. JAMA 2003; 289:2500–2502.
- Choi K, Thacker SB. From the centers for disease control. Improved accuracy and specificity of forecasting deaths attributed to pneumonia and influenza. J Infect Dis 1981; 144:606–608.
- Choi K, Thacker SB. An evaluation of influenza mortality surveillance, 1962–1979. II. Percentage of pneumonia and influenza deaths as an indicator of influenza activity. Am J Epidemiol 1981; 113:227–235.
- Box G, Jenkins GM. Time‐Series Analysis; Forecasting and Control. San Francisco: Holden‐Day, 1970.
- Meltzer MI, Neuzil KM, Griffin MR, Fukuda K. An economic analysis of annual influenza vaccination of children. Vaccine 2005; 23:1004–1014.
- Prosser LA, Bridges CB, Uyeki TM et al. Health benefits, risks, and cost‐effectiveness of influenza vaccination of children. Emerg Infect Dis 2006; 12:1548–1558.
Source: PubMed